StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) shareholders

RGCNasdaqMedicinal Chemicals & Botanical Products
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.55−0.17 (-3.60%)

Close on Nov 17, 2026Market cap $2.26BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.3%
1M of 496M shares
Institutional holders
35
16 new, 12 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Yat-Gai Au
Joint filing with Regencell (BVI) Limited (86.20%)
437,896,11688.60%13D (active) amendmentJul 11, 2025
Regencell (BVI) Limited
Joint filing with Yat-Gai Au (86.20%)
11,221,82186.20%13D (active) amendmentMar 10, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RGCValueChange% of portfolio
Geode Capital Management, LLC422,0110.09%$2.57M+6,4420.00%
Alyeska Investment Group, L.P.416,2610.08%$2.54MNew0.01%
Legal & General Group Plc128,0000.03%$778.97K+118,0970.00%
Jane Street Group, LLC98,3480.02%$598.94KNew0.00%
XTX Topco Ltd60,0610.01%$365.77KNew0.00%
Amundi47,1590.01%$287.20K+38,5640.00%
UBS Group AG43,2080.01%$263.14K+19,3230.00%
Quadrature Capital Ltd41,7500.01%$254.26KNew0.00%
Susquehanna International Group, Llp23,1290.00%$140.86KNew0.00%
Squarepoint Ops LLC22,0360.00%$134.20K−4,5770.00%
Fox Run Management, L.L.C.20,6910.00%$126.01KNew0.02%
CIBC Asset Management Inc15,2920.00%$93.13KNew0.00%
Bank Of America Corp /De/14,9940.00%$91.31K−2,1780.00%
Two Sigma Investments, LP14,4060.00%$87.73KNew0.00%
Vident Advisory, LLC11,1990.00%$68.20K−18,3890.00%
Morgan Stanley5,0520.00%$30.77K−15,0260.00%
BlackRock, Inc.4,9250.00%$29.99K−320.00%
State of Wyoming4,0700.00%$24.79KNew0.00%
Federation des caisses Desjardins du Quebec2,8030.00%$17.07K+5720.00%
Aquatic Capital Management LLC2,0580.00%$12.53KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026351M0.3%16 / 106 / 121M0M
Q1 2026311M0.1%18 / 64 / 40M0M
Q4 2025171M0.1%7 / 44 / 60M0M
Q3 2025161M0.1%7 / 45 / 50M0M
Q2 2025141M0.1%11 / 21 / 20M0M
Q1 202550M0.1%3 / 11 / 10M1M
Q4 202431M0.2%1 / 10 / 01M0M
Q3 202421M0.1%1 / 10 / 11M0M
Q2 202430M0.0%0 / 01 / 00M0M
Q1 202430M0.0%0 / 01 / 00M1M
Q4 202331M0.1%1 / 00 / 21M0M
Q3 202340M0.0%2 / 10 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Yat-Gai AuChief Executive Officer, Director, 10% owner437,896,11688.31%Mar 18, 2026
James Wai Hong ChungCOO and Chief Strategy Officer, Director––Mar 18, 2026
Ho Yau ChanFinancial Controller––Mar 18, 2026
Yat-Pui AuChief Business Officer581,5140.12%Mar 18, 2026
William Wing Yan Dr LoDirector485,6290.10%Nov 17, 2026
Evana Yee Wah HuiDirector––May 29, 2026
Margaret Hoor Han LoDirector604,0500.12%Mar 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
William Wing Yan Dr Lo
Director
Nov 17, 2026Option exercise+36,001$0.84$30.24K485,629

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.62%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-20.7%
From 0M shares
Short volume, 20 days
47.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Regencell Bioscience's stock actually held short. Settlement fails (shares not delivered on time) peaked at 35,922 shares on Sep 10, 2026 over the last 90 days.

Congress trades

3 trades in Regencell Bioscience reported by 1 member of the House

MemberTypeTradedAmountFiled
Lois Frankel
FL22
SoldJan 9, 2018$1K–15KJan 23, 2018
Lois Frankel
FL22
SoldJan 8, 2018$1K–15KJan 23, 2018
Lois Frankel
FL22
SoldDec 8, 2017$1K–15KDec 20, 2017

See a number that looks wrong?